معرفی
Nicole Ashpole serves as an Adjunct Associate Professor in Pharmacology at the University of Mississippi. Her academic appointment reflects specialized expertise in neuropharmacology with focus on cannabinoid therapeutics and insulin-like growth factor signaling pathways, contributing to the university's research profile in neuroscience and drug development.
Dr. Ashpole earned her Ph.D. in Neuroscience from Indiana University-Bloomington in 2012, establishing her foundation in cellular and molecular neuroscience before transitioning to pharmacological applications.
Her research program centers on two major interconnected themes: the therapeutic potential of minor cannabinoids (particularly cannabichromene) for pain management and neuroprotection, and the role of insulin-like growth factor-1 (IGF-1) in cognitive health and cerebrovascular function. She demonstrates particular expertise in identifying sex-specific differences in neurological responses, with significant work on HIV-related neuropathology and chemotherapy-induced neuropathy. Her methodological approach combines preclinical animal models with cellular and molecular techniques to investigate mechanisms of action.
Analysis of Dr. Ashpole's publication trajectory through 2025 reveals increasingly sophisticated investigations into cannabinoid pharmacology and IGF-1 signaling. Recent work demonstrates progression from basic mechanism studies to therapeutic development, with emphasis on translational applications for neuropathic pain and stroke recovery. Her research consistently addresses critical gaps in understanding sex differences in treatment responses, which has significant implications for personalized medicine approaches in neurology.
Dr. Ashpole maintains an active laboratory investigating cannabinoid interactions with the endocannabinoid system and IGF-1's neuroprotective mechanisms. Her work bridges basic neuroscience with clinical applications, employing techniques including confocal microscopy for neural imaging, behavioral testing in mouse models, and molecular analyses of signaling pathways. As an Adjunct Associate Professor, she likely contributes to pharmacology education while maintaining her research program focused on developing novel therapeutic approaches for neurological conditions.
